Quarterly report pursuant to Section 13 or 15(d)

Net Loss Per Share (Tables)

v3.23.3
Net Loss Per Share (Tables)
9 Months Ended
Sep. 30, 2023
Earnings Per Share [Abstract]  
Schedule of Anti-Dilutive Securities that Could Potentially be Dilutive in Future

The table below represents the anti-dilutive securities that could potentially be dilutive in the future for the periods presented:

 

 

As of September 30,

 

(in shares of common stock)

 

2023

 

 

2022

 

Stock options

 

 

1,047,327

 

 

 

1,806,287

 

Restricted stock units

 

 

22,538,032

 

 

 

15,172,238

 

FP Combination Warrants

 

 

8,291,704

 

 

 

8,291,704

 

Combination Warrants

 

 

2,763,902

 

 

 

2,763,902

 

Public Warrants

 

 

19,221,960

 

 

 

11,499,960

 

Private Placement Warrants

 

 

78,000

 

 

 

7,800,000

 

2027 Warrants

 

 

17,253,279

 

 

 

 

RDO Warrants

 

 

29,000,000

 

 

 

 

Placement Agent Warrants

 

 

2,030,000

 

 

 

 

CMPO Warrants

 

 

23,214,290

 

 

 

 

CMPO Placement Agent Warrants

 

 

1,625,000

 

 

 

 

PIPE Investment Obligation

 

 

13,554,217

 

 

 

12,711,864

 

Conversion Option Derivative

 

 

37,781,575

 

 

 

 

Schedule of Computations of Basic and Diluted Net Loss Per Share

The computations of basic and diluted net loss per share for the periods presented were as follows:

 

 

 

Three Months Ended September 30,

 

 

Nine Months Ended September 30,

 

(in thousands, except per share and share amounts)

 

2023

 

 

2022

 

 

2023

 

 

2022

 

Numerator:

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

$

(26,429

)

 

$

(27,355

)

 

$

(109,004

)

 

$

(131,001

)

Denominator:

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average shares outstanding - basic and diluted

 

 

178,624,492

 

 

 

143,276,708

 

 

 

159,856,355

 

 

 

123,317,997

 

Net loss per share - basic and diluted

 

$

(0.15

)

 

$

(0.19

)

 

$

(0.68

)

 

$

(1.06

)